TTY Biopharm Company Limited (TPEX:4105)

Taiwan · Delayed Price · Currency is TWD

75.40

+0.90 (1.21%)

May 8, 2026, 1:30 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Adjustments and Eliminations			-	-268.62M	-274.72M	-231.74M	-138.25M
Healthcare Business Group			195.63M	581.66M	221.48M	212.63M	264.87M
Healthcare Business Group Growth			-66.37%	162.62%	4.16%	-19.72%	12.76%
Other Department			65.44M	106.64M	270.72M	196.05M	19.69M
Other Department Growth			-38.64%	-60.61%	38.09%	895.68%	-1.69%
Reinvestment Segment			814.45M	747.28M	-	-	-
Reinvestment Segment Growth			8.99%	-	-	-	-
Cancer Drug Business Group			2.43B	2.34B	2.77B	2.61B	3.03B
Cancer Drug Business Group Growth			3.78%	-15.44%	6.18%	-13.82%	10.15%
Export and OEM Group			796.70M	653.68M	-	-	-
Export and OEM Group Growth			21.88%	-	-	-	-
Anti-infection medicine segment			1.20B	899.62M	1.14B	989.45M	786.66M
Anti-infection medicine segment Growth			33.77%	-20.80%	14.79%	25.78%	11.16%
Cardiovascular and Gastrointestinal Drugs Business Group			-	-	413.48M	447.86M	507.67M
Cardiovascular and Gastrointestinal Drugs Business Group Growth			-	-	-7.68%	-11.78%	-1.55%
Total			5.51B	5.06B	4.54B	4.22B	4.47B
Total Growth			8.77%	11.60%	7.43%	-5.47%	10.66%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Taiwan			4.84B	4.60B	4.25B	3.93B	3.73B
Taiwan Growth			5.24%	8.33%	8.01%	5.49%	9.58%
America			265.71M	59.43M	-	-	-
America Growth			347.07%	-	-	-	-
Other Countries			398.66M	402.12M	289.25M	278.03M	320.27M
Other Countries Growth			-0.86%	39.02%	4.04%	-13.19%	74.05%
Europe			-	-	-	12.20M	418.93M
Europe Growth			-	-	-	-97.09%	-7.07%
Total			5.51B	5.06B	4.54B	4.22B	4.47B
Total Growth			8.77%	11.60%	7.43%	-5.47%	10.66%

Source: S&P Global Market Intelligence.